10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 1, 2007.

or

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                                                                        to                                                                       

Commission File Number:  0-17196

MGP INGREDIENTS, INC.

(Exact name of registrant as specified in its charter)

KANSAS	48-0531200
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
100 Commercial Street, Atchison Kansas	66002
(Address of principal executive offices)	(Zip Code)

(913) 367-1480

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  x Yes o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer.  See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.  (Check One)
               o Large accelerated filer               x Accelerated filer               o Non-accelerated filer

Indicated by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
               oYes x No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common stock, no par value

16,489,890 shares outstanding

as of April 1, 2007

INDEX

			Page
PART I. FINANCIAL INFORMATION
Item 1.		Financial Statements
	Report of Independent Registered Public Accounting Firm		3
	Condensed Consolidated Balance Sheets		4
	Condensed Consolidated Statements of Income		6
	Condensed Consolidated Statements of Cash Flows		7
	Notes to Condensed Consolidated Financial Statements		8
Item 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations	14
Item 3.		Quantitative and Qualitative Disclosures About Market Risk	23
Item 4.		Controls and Procedures	23
PART II. OTHER INFORMATION
Item 1.		Legal Proceedings	24
Item 2.		Unregistered Sales of Equity Securities and Use of Proceeds.	24
Item 6.		Exhibits	24

2

Report of Independent Registered Public Accounting Firm

Audit Committee, Board of Directors and Stockholders

MGP Ingredients, Inc.

Atchison, Kansas

We have reviewed the accompanying condensed consolidated balance sheet of MGP Ingredients, Inc. as of April 1, 2007 and the related condensed consolidated statements of income for the three-month and nine-month periods ended April 1, 2007 and March 31, 2006 and cash flows for the nine-month periods ended April 1, 2007 and March 31, 2006.  These interim financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States).  A review of interim financial information consists principally of applying analytical procedures to financial data and making inquiries of persons responsible for financial and accounting matters.  It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board, the objective of which is the expression of an opinion regarding the financial statements taken as a whole.  Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with accounting principles generally accepted in the United States of America.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet as of June 30, 2006 and the related consolidated statements of income, stockholders’ equity and cash flows for the year then ended (not presented herein); and in our report dated August 22, 2006, we expressed an unqualified opinion on those consolidated financial statements.  In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of June 30, 2006 is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

	/s/ BKD, LLP
Kansas City,Missouri
May 9, 2007

3

MGP INGREDIENTS, INC.

CONSOLIDATED BALANCE SHEETS

	April 1,			June 30,
	2007			2006
	Unaudited
	Dollars in thousands, except share and per  share amounts
ASSETS
Current Assets
Cash and cash equivalents	$	2,410		$	14,495
Segregated cash and investments	3,954			2,291
Receivables, net of allowance of $320 at April 1, 2007and June 30, 2006.	38,369			32,197
Inventories	35,408			30,467
Prepaid expenses	2,516			1,098
Deferred income taxes	5,696			1,990
Refundable income taxes	1,724			—
Total current assets	90,077			82,538
Property and Equipment, at cost	355,095			336,428
Less accumulated depreciation	(224,945		)	(214,593		)
Property and equipment, net	130,150			121,835
Other Assets	201			211
Total assets	$	220,428		$	204,584

See Notes to Condensed Consolidated Financial Statements

4

	April 1,			June 30,
	2007			2006
	Unaudited
	Dollars in thousands, except share
	and per share amounts
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Current maturities of long-term debt	$	3,704		$	3,796
Revolving credit facility	2,000			—
Accounts payable	17,683			10,661
Accrued expenses	8,522			10,028
Income taxes payable	—			4,210
Deferred revenue	8,228			9,374
Total current liabilities	40,137			38,069
Long-Term Debt	9,690			12,355
Post Retirement Benefits	6,823			6,554
Deferred Income Taxes	17,106			12,694
Stockholders’ Equity
Capital stock
Preferred, 5% non-cumulative; $10 par value; authorized 1,000 shares; issued and outstanding 437 shares	4			4
Common stock
No par value; authorized 40,000,000 shares; issued 19,530,344 shares	6,715			6,715
Additional paid-in capital	9,641			7,203
Retained earnings	147,221			136,267
Accumulated other comprehensive loss – cash flow hedges	(1,542		)	(482		)
	162,039			149,707
Treasury stock, at cost
Common; April 1, 2007 – 3,040,454 shares, June 30, 2006 - 3,256,784 shares	(15,367		)	(14,795		)
Total stockholders’ equity	146,672			134,912
Total liabilities and stockholders’ equity	$	220,428		$	204,584

See Notes to Condensed Consolidated Financial Statements

5

MGP INGREDIENTS, INC.

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

	Quarter Ended						Year to Date
	April 1, 2007			March 31,  2006			April 1, 2007			March 31,  2006
	Dollars in thousands, except per share amounts
Net sales	$	93,807		$	79,422		$	266,447		$	232,139
Cost of sales	85,467			71,348			226,847			206,141
Gross profit	8,340			8,074			39,600			25,998
Selling, general and administrative expenses	5,432			5,471			15,399			16,219
Other operating income (expense)	(203		)	150			568			599
Income from operations	2,705			2,753			24,769			10,378
Other income, net	585			417			1,145			1,054
Interest expense	(208		)	(350		)	(659		)	(1,182		)
Income before income taxes	3,082			2,820			25,255			10,250
Provision for income taxes	904			737			9,266			3,618
Net income	2,178			2,083			15,989			6,632
Other comprehensive income (loss), net of tax:	(995		)	330			(1,060		)	588
Comprehensive income	$	1,183		$	2,413		$	14,929		$	7,220
Per Share Data
Total basic earnings per common share	$	0.13		$	0.13		$	0.97		$	0.41
Total diluted earnings per common share	$	0.13		$	0.12		$	0.94		$	0.40
Dividends per common share	$	—		$	—		$	0.20		$	0.15

See Notes to Condensed Consolidated Financial Statements

6

MGP INGREDIENTS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

Year to Date Ended

(Unaudited)

	April 1,			March 31,
	2007			2006
	Dollars in thousands
Cash Flows from Operating Activities
Net income	$	15,989		$	6,632
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10,437			9,130
Gain on sale of assets	(3		)	(14		)
Deferred income taxes	706			(299		)
Changes in working capital items:
Segregated cash and investments	(1,663		)	—
Accounts receivable	(6,172		)	(3,927		)
Inventories	(6,001		)	(8,231		)
Accounts payable and accrued expenses	3,403			1,207
Deferred revenue	(1,146		)	(1,181		)
Income taxes payable/receivable	(5,934		)	3,808
Other	(1,418		)	(818		)
Net cash provided by operating activities	8,198			6,307
Cash Flows from Investing Activities
Additions to property and equipment	(16,778		)	(13,732		)
Proceeds from disposition of equipment	87			51
Net cash used in investing activities	(16,691		)	(13,681		)
Cash Flows from Financing Activities
Purchase of treasury stock	(1,938		)	—
Proceeds from stock plans	2,446			1,477
Principal payments on long-term debt	(2,757		)	(11,416		)
Proceeds from issuance of long-term debt	—			7,000
Proceeds from line of credit	2,000			6,000
Dividends paid	(3,343		)	(2,485		)
Net cash provided by (used in) financing activities	(3,592		)	576
Decrease in cash and cash equivalents	(12,085		)	(6,798		)
Cash and cash equivalents, beginning of year	14,495			10,384
Cash and cash equivalents, end of year	$	2,410		$	3,586

See Notes to Condensed Consolidated Financial Statements

7

MGP INGREDIENTS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1.  Basis of Presentation.

The accompanying unaudited condensed consolidated financial statements reflect all adjustments that are, in the opinion of the Company’s management, necessary to fairly present the financial position, results of operations and cash flows of the Company.  Those adjustments consist only of normal recurring adjustments.  The condensed consolidated balance sheet as of June 30, 2006 has been derived from the audited consolidated balance sheet of the Company as of that date.  Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted.  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in the Company’s Form 10-K Annual Report for the fiscal year ended June 30, 2006 filed with the Securities and Exchange Commission.  The results of operations for the period are not necessarily indicative of the results to be expected for the full year.

The Company’s most recently completed fiscal year ended on June 30, 2006.  On June 8, 2006 the Board of Directors amended the Company’s Bylaws to effect a change in the fiscal year from a fiscal year ending June 30 to a 52/53 week fiscal year.  The Company’s 2007 fiscal year will end on July 1, 2007.  As a result of this change, the third quarter of fiscal 2007 as well as the year to date period ended April 1, 2007 includes one additional day than the same periods in fiscal  2006, the results of which are included in the accompanying condensed consolidated financial statements for the quarter and year to date ended April 1, 2007 and March 31, 2006.

Note 2.  Earnings Per Share.

Basic earnings per share data is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the period.  Potentially dilutive instruments are stock options and unvested restricted stock awards.  The following is a reconciliation from the weighted average shares used for the basic earnings per share computation to the shares used for the diluted earnings per share computation for each of the quarter and year-to-date periods ended April 1, 2007 and March 31, 2006, respectively.

	Quarter Ended		Year to Date
	April 1, 2007	March 31,  2006	April 1, 2007	March 31,  2006
Weighted average shares:
Basic Shares:	16,471,593	16,136,450	16,406,585	16,068,767
Additional weighted average shares attributable to:
Stock options:	242,211	354,557	246,080	340,318
Unvested restricted stock awards:	272,297	397,269	279,499	357,882
Diluted Shares:	16,986,101	16,888,276	16,932,164	16,766,967

8

Note 3.  Contingencies.

There are various legal proceedings involving the Company and its subsidiaries. Management considers that the aggregate liabilities, if any, arising from such actions would not have a material adverse effect on the consolidated financial position or operations of the Company.

The Company was previously in negotiations with the Illinois Attorney General’s Office and the Illinois Environmental Protection Agency (“IEPA”) to settle an enforcement proceeding related to emissions at the Pekin, Illinois location.  The Company reached a settlement with the IEPA.  A Stipulation and Proposal for Settlement  has been signed providing for a total payment  by  the Company of $500,000, including a contribution to a state special project fund. The settlement proposal  was submitted to the Illinois Pollution Control Board (“the Board”) for final judgment.  The  Board accepted and approved the settlement proposal on January 26, 2007, and the Company paid the settlement on March 5, 2007.

Note 4.  Operating Segments.

The Company is a fully integrated producer of ingredients and distillery products.  Products included within the ingredients segment consist of starches, including commodity wheat starch and modified and specialty wheat and potato starches, proteins, including commodity wheat gluten, specialty wheat, soy and other proteins, and mill feeds.  Distillery products consist of food grade alcohol, including beverage alcohol and industrial alcohol, fuel alcohol, commonly known as ethanol, and distiller’s grain and carbon dioxide, which are by-products of the Company’s distillery operations.

The operating profit for each segment is based on net sales less identifiable operating expenses.  Interest expense, investment income and other general miscellaneous expenses have been excluded from segment operations and classified as Corporate.  Receivables, inventories and equipment have been identified with the segments to which they relate.  All other assets are considered as Corporate.

9

	Quarter Ended						Year to Date
	April 1,			March 31,			April 1,			March 31,
(in thousands)	2007			2006			2007			2006
Sales to Customers
Ingredients	$	19,143		$	22,324		$	51,096		$	66,786
Distillery products	74,664			57,098			215,351			165,353
Total	93,807			79,422			266,447			232,139
Depreciation
Ingredients	1,553			1,587			4,836			4,685
Distillery products	1,751			1,394			5,147			4,044
Corporate	135			135			444			391
Total	3,439			3,116			10,427			9,120
Income before Income Taxes
Ingredients	(1,926		)	(2,175		)	(10,063		)	(4,568		)
Distillery products	5,687			5,831			36,907			16,636
Corporate	(679		)	(836		)	(1,589		)	(1,818		)
Total	$	3,082		$	2,820		$	25,255		$	10,250

	April 1, 2007		June 30, 2006
Identifiable Assets Ingredients	$	82,782	$	72,992
Distillery products	109,620		96,222
Corporate	28,026		35,370
Total	$	220,428	$	204,584

Note 5.  Pension and Post Retirement Benefit Obligations.

Post Retirement Benefits:

The Company and its subsidiaries provide certain post-retirement health care and life benefits to all employees.  The liability for such benefits is unfunded.  The Company uses a May 31 measurement date for the plan.

10

The components of the Net Periodic Benefit Cost for the quarter and year to date periods ended April 1, 2007 and March 31, 2006, respectively, are as follows:

	Quarter Ended						Year to Date
(in thousands)	April 1, 2007			March 31, 2006			April 1, 2007			March 31, 2006
Service cost	$	61		$	74		$	183		$	222
Interest cost	115			74			345			222
Prior service cost	(9		)	(9		)	(27		)	(27		)
(Gain) loss	8			—			24			—
Total post-retirement benefit cost	$	175		$	139		$	525		$	417

The Company previously disclosed in its financial statements for the year ended June 30, 2006, amounts expected to be paid to plan participants.  There have been no revisions to these estimates and there have been no changes in the estimate of total employer contributions expected to be made for the fiscal year ended July 1, 2007.

Total employer contributions for the quarter ended April 1, 2007 were $132,000.

The Medicare Prescription Drug Improvement Modernization Act of 2003 (the Act) provides certain drug benefits under Medicare Part D, as well as a federal subsidy to sponsors of retiree health care benefit plans that provide benefits at least actuarially equivalent to Medicare Part D.  The Company has been unable to conclude whether the benefits provided under the plan are actuarially equivalent to Medicare Part D.  Accordingly, the net periodic post-retirement benefit costs above do not reflect any amount associated with the subsidiary.

Pension Benefits:

The Company and its subsidiaries also provide defined retirement benefits to certain employees covered under collective bargaining agreements.  Under the collective bargaining agreements, the Company’s pension funding contributions are a function of the wages paid and are determined as a percentage of wages paid.  The funding is divided between the defined benefit plan and a 401(k) plan.  It has been management’s policy to fund the defined benefit plan first in order to render it adequately funded.  Any remaining amounts have been used to fund the 401(k) plan.  The collective bargaining agreements allow the pension benefits defined under the agreements to be reduced if the funding as described herein is insufficient to provide for such defined benefits.  The Company has previously accounted for this plan as a defined contribution plan, but has recently made the determination that the plan qualifies for defined benefit plan treatment. The differences in this reporting, including disclosures, are not material to the financial statements.  The Company uses a June 30 measurement date for the plan.

The components of the Net Periodic Benefit Cost for the quarter and year to date periods ended April 1, 2007 and March 31, 2006, respectively, are as follows:

11

	Quarter Ended						Year to Date
(in thousands)	April 1, 2007			March 31, 2006			April 1, 2007			March 31, 2006
Service cost	$	130		$	131		$	390		$	393
Interest cost	25			15			76			45
Expected return on plan assets	(25		)	(14		)	(74		)	(42		)
Prior service cost	6			5			19			15
(Gain) loss	(2		)	—			(8		)	—
Total pension benefit cost	$	134		$	137		$	403		$	411

There were no employer contributions for the quarter ended April 1, 2007.  Management anticipates funding the plan for fiscal 2007 in the first quarter of fiscal 2008.

Note 6.  4.90% Industrial Revenue Bond Obligation.

On December 28, 2006, the Company engaged in an industrial revenue bond transaction with the City of Atchison, Kansas pursuant to which the City (i) under a trust indenture, (“the Indenture”), issued $7.0 million principal amount of its industrial revenue bonds (“the Bonds”) to the Company and used the proceeds thereof to acquire from the Company its newly constructed office building and technical center in Atchison, Kansas, (“the Facilities”) and (ii) leased the Facilities back to the Company under a capital lease (“the Lease”).  The bonds mature on December 1, 2016 and bear interest, payable annually on December 1st of each year commencing December 1st, 2007 at the rate of 4.90% per annum.  Basic rent under the lease is payable annually on December 1st in an amount sufficient to pay principal and interest on the bonds.  The Indenture and Lease contains certain provisions, covenants and restrictions customary for this type of transaction.  In connection with the transaction, the Company agreed to pay the city an administrative fee of $50,000 payable over 10 years.

In connection with the foregoing transaction, the Company also entered a Fifth Amendment to its Line of Credit Loan Agreement with Commerce Bank excluding the application of specified sections of the Line of Credit Loan Agreement to the transaction.

The purpose of the transaction was to facilitate certain property tax abatement opportunities available to the Company related to the newly constructed Facilities.  The Company will be eligible to apply for 10 years property tax abatement on the facilities acquired with bond proceeds.  These property tax abatements terminate upon maturity of the Bonds on December 1st, 2016.  The issuance of the Bonds is integral to the tax abatement process.  Financing for the Facilities has been provided internally from the Company’s operating cash flow.  Accordingly, upon consummation of the transaction and issuance of the Bonds, the Company acquired all bonds issued for $7.0 million excluding transaction fees.  As a result, the Company holds all of the outstanding Bonds.  It is management’s intention to hold these bonds to their maturity.  Because the Company holds all outstanding bonds, management considers the debt de-facto cancelled and, accordingly, no amount for these Bonds is reflected as debt outstanding on the Balance Sheet as of April 1, 2007.

12

Note 7.  Recently Issued Accounting Pronouncements.

In June 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in Income taxes (“FIN 48”).  FIN 48, which is an interpretation of SFAS No. 109, “Accounting for Income Taxes,” provides guidance on the manner in which tax positions taken or to be taken on tax returns should be reflected in an entity’s financial statements prior to their resolution with taxing authorities.  The Company is required to adopt FIN 48 during the first quarter of fiscal 2008.  The Company is currently evaluating the requirements of FIN 48 and has not yet determined the impact, if any; this interpretation may have on its consolidated financial statements.

In September 2006, the FASB released SFAS Statement No. 158 (“SFAS 158”), Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans, an amendment of FASB Statements No. 87, 88, 106 and 132(R). SFAS 158 requires the Company to recognize in its statement of financial position an asset for a defined benefit postretirement plan’s over funded status or a liability for a plan’s under funded status.  This section of the standard is effective for the Company as of the end of its fiscal year on July 1, 2007.  The statement also eliminates the option of using a measurement date prior to the Company’s fiscal year-end effective June 28, 2009.  SFAS 158 provides two methods for transition to a fiscal year-end measurement date, both of which are to be applied prospectively.  Under the first approach, plan assets are measured on May 31, 2008 and then re-measured on June 30, 2008 (the first day of the fiscal year ended June 28, 2009).  Under the second approach, a 13-month measurement will be determined on May 31, 2008 that will cover the period until the fiscal year-end measurement is required on June 28, 2009.  The Company currently uses a measurement date prior to its fiscal year-end and is currently evaluating which measurement transition alternative it will use.  SFAS 158 is not expected to have a material impact on the Company’s results of operations, financial condition, liquidity or compliance with debt covenants.

13

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

FORWARD-LOOKING STATEMENTS

This section contains forward-looking statements as well as historical information.  All statements, other than statements of historical facts, included in this Quarterly Report on Form 10-Q regarding the prospects of our industry and our prospects, plans, financial position and business strategy may constitute forward-looking statements.  In addition, forward-looking statements are usually identified by or are associated with such words as “intend,” “plan”, “believe,” “estimate,” “expect,” “anticipate,” “hopeful,” “should,” “may,” “will”, “could” and or the negatives of these terms or variations of them or similar terminology.  They reflect management’s current beliefs and estimates of future economic circumstances, industry conditions, Company performance and financial results and are not guarantees of future performance.  All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those contemplated by the relevant forward-looking statement.  Important factors that could cause actual results to differ materially from our expectations include, among others:  (i) the availability and cost of grain, (ii) fluctuations in gasoline prices, (iii) fluctuations in energy costs, (iv) competitive environment and related market conditions, (vi) our ability to realize operating efficiencies, (vii) the effectiveness of our hedging programs, (viii) access to capital and (ix) actions of governments.  For further information on these and other risks and uncertainties that may affect our business, see Item 1A. Risk Factors of our Annual Report on Form 10-K for the fiscal year ended June 30, 2006.

RESULTS OF OPERATIONS

General

Reference is made to Management’s Discussion and Analysis of Financial Condition and Results of Operations—General, incorporated by reference to Item 7 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2006 for certain general information about our principal products and costs.

Critical Accounting Policies

Reference is made to Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies, incorporated by reference to Item 7 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2006 for accounting policies which are considered by management to be critical to an understanding of the Company’s financial statements.

DEVELOPMENTS IN THE INGREDIENTS SEGMENT

A previously reported loss of sales to a major pet industry customer is the primary reason for the decline in our ingredient sales.  Sales of specialty ingredients for food applications were higher compared to the third quarter a year ago due principally to an improvement in the average prices for both specialty proteins and starches.

Recently, we have taken steps to size the ingredients portion of our business, particularly in the food area, to more appropriately align with current production and sales requirements.  These steps have included adjustments in the size of our workforce across multiple disciplines within our organization.  We are also concentrating our production and marketing efforts on supplying our core base of loyal customers with a

14

more select array of high quality, premium ingredients that address nutritional, sensory and convenience issues and that can help build value while making more efficient use of our existing capacities.  We are putting more sales and marketing focus on fewer core products, specifically Fibersym®, Arise®, Wheatex®, and FiberRite™ RW.  We also continue to place emphasis on research and development efforts and have revamped the responsibilities of our technical applications scientists, who will perform a significantly more integral role as solutions providers to our customers.  In February, 2007, our science and technology staffs relocated to our new technical innovation center in Atchison, Kansas, that provides enhanced facilities for research and development initiatives as well as finished product formulations and testing.  As previously announced, construction of the technical center and our new corporate office building in Atchison began in January, 2006.

In recent years, we have curtailed the production of vital wheat gluten due to unfavorable competitive conditions caused by low valued imports.  However, the recent recall of pet food products containing Chinese wheat flour misrepresented as wheat gluten has caused heightened demand for our gluten.  In response to this demand, we are taking action to increase wheat gluten production at our plants in Atchison and Pekin, Illinois.  We expect this increase, along with improved pricing,  to begin impacting the results of our ingredients operations during the fourth quarter.  If demand remains high and we are able to timely increase production, we anticipate that our recent wheat gluten production rate could increase threefold by the start of fiscal 2008. As noted, this forward looking statement is subject to sustained market demand and our successful implementation of efforts to restore our gluten capacity.    While this situation warrants our short-run focus on rapidly increasing wheat gluten production, we maintain as our long-term goal the continued development and commercialization of our value-added wheat proteins, as well as value-added wheat starches.

DEVELOPMENTS IN THE DISTILLERY PRODUCTS SEGMENT

During the third quarter of fiscal 2007, we continued to implement measures to improve our capacity and strengthen alcohol production efficiencies.  These measures permitted higher throughput, which contributed to distillery profits in the quarter.  The capacity improvements were part of a previously announced plan to incrementally expand our alcohol production capacity by approximately 15 percent.  Complete phase-in of this plan is scheduled to occur by late this summer at a total projected investment of $10 million.

15

SEGMENT RESULTS

The following is a summary of revenues and pre-tax profits/(loss) allocated to each reportable operating segment for the quarterly and year-to-date periods ended April 1, 2007 and March 31, 2006.

	Quarter Ended						Year-to-Date
(in thousands)	April 1, 2007			March 31, 2006			April 1, 2007			March 31, 2006
Ingredients
Net Sales	$	19,143		$	22,324		$	51,096		$	66,786
Pre-Tax Income (Loss)	(1,926		)	(2,175		)	(10,063		)	(4,568		)
Distillery products
Net Sales	$	74,664		$	57,098		$	215,351		$	165,353
Pre-Tax Income (Loss)	5,687			5,831			36,907			16,636

GENERAL

Our total earnings in the third quarter of fiscal 2007 improved slightly compared to the third quarter of fiscal 2006 as the result of a reduced loss in our ingredients segment.  Profitability in the distillery products segment was slightly lower than a year ago due to significantly higher prices for corn, the principal raw material used in our alcohol production process.  While our third quarter performance in the ingredients segment improved over both the year ago period as well as the second quarter of fiscal 2007, it continued to be negatively affected by reduced sales of certain of our higher valued specialty ingredients for non-food applications, principally in the pet area.  Increased raw material prices for wheat compared to the prior year’s third quarter also contributed to the loss in this segment.  Sales of specialty ingredients for food applications, meanwhile, improved considerably over both the third quarter of fiscal 2006 and the second quarter of the current fiscal year.

The increase in total sales revenue compared to the third quarter of fiscal 2006 resulted from increased sales in the distillery products segment.  Distillery products sales rose by approximately $17.6 million, or approximately 31 percent, above distillery products sales in last year’s third quarter.  Sales of total ingredients, on the other hand, decreased by approximately $3.2 million, or 14 percent, compared to a year ago.

The increase in distillery products sales resulted from higher unit sales and improved selling prices for fuel grade alcohol combined with improved prices for food grade alcohol over the comparable period in the prior year.  Sales of distillers feed, the principal by-product of our alcohol production process, also increased compared to the prior year’s third quarter due to an improvement in selling prices, which offset lower unit sales.

The decrease in ingredients sales was principally attributable to the decline in sales of specialty ingredients for non-food applications.  This was partially offset by the increase in sales of specialty ingredients for food applications.  Sales of commodity ingredients also increased compared to the prior year’s third quarter mainly due to higher sales of commodity wheat gluten, which more than offset lower sales of commodity starch.

16

The decline in sales of specialty ingredients for non-food applications resulted primarily from decreased sales of our MGPI Chewtex™ line of protein- and starch-based resins, which are produced for use in the manufacture of pet chews and related treats.  Sales of ingredients for use in personal care products increased modestly compared to the prior year’s third quarter.  The improvement in sales of specialty ingredients for food applications was principally due to higher average prices for our specialty proteins and specialty starches.  The increase in sales of commodity gluten was due to higher unit sales and improved prices.  The reduction in commodity starch sales revenue was due to lower unit sales, as the average selling price was higher than a year ago.

INGREDIENTS

Total ingredient sales in the third quarter of fiscal 2007 decreased by approximately $3.1 million, or approximately 14 percent, compared to the prior year’s third quarter.  This principally was due to a $4.8 million, or 64 percent, reduction in sales of specialty ingredients for non-food applications, which more than offset a $1.3 million, or approximately 12 percent, increase in sales of specialty ingredients for food applications.  Sales of commodity ingredients rose by approximately $357,000, or 11 percent.  This was due to an increase of approximately $675,000, or 32 percent, in sales of commodity gluten, which was partially offset by a $318,000, or 25 percent decline in sales of commodity starch.  Sales of mill feed and other mill products decreased by $82,000, or 11 percent.  The decrease in sales of specialty ingredients for non-food applications principally occurred in sales of our Chewtex® protein- and starch-based resins for use in pet industry products due to loss of sales to a major customer.  The increase in sales of specialty ingredients for food applications compared to the prior year’s third quarter benefitted from higher unit sales of our Fibersym®line of specialty starch and Arise® wheat protein isolates.

DISTILLERY PRODUCTS

Total sales of our distillery products in the third quarter of fiscal 2007 rose by approximately $17.6 million, or 31 percent, compared to the third quarter of fiscal 2006.  This improvement was due to a $12.9 million, or 45 percent, increase in sales of fuel grade alcohol and a $4.1 million, or 19 percent, increase in sales of food grade alcohol.  The increased sales of fuel grade alcohol resulted from higher average selling prices and higher unit sales.  In the food grade area, sales of alcohol for industrial applications rose by $4.4 million, or 29 percent, as the result of higher unit sales and prices.  Meanwhile, sales of food grade alcohol for beverage applications decreased by $339,000, or 6 percent, due to a decline in unit sales, which offset improved prices.    Sales of distillers feed, the principal by-product of the alcohol production process, increased by approximately $567,000, or nearly 8 percent, as a result of higher selling prices.

SALES

Net sales in the third quarter of fiscal 2007 increased by $14.4 million, or 18 percent, above net sales in the third quarter of fiscal 2006.  This improvement was due to increased distillery products sales.  Ingredients sales decreased compared to the prior year.  The increase in distillery products sales resulted from a combination of increased unit sales and prices for fuel grade alcohol, higher unit sales and prices for food grade industrial alcohol, and improved prices for beverage alcohol and distillers feed.  The decline in ingredients sales principally resulted from reduced unit sales of specialty ingredients for non-food applications together with lower unit sales of commodity starches.  These decreases were partially offset by increased sales of specialty ingredients for food applications combined with increased sales of commodity gluten.

17

For the first nine months of fiscal 2007, net sales increased by $34.3 million, or nearly 15 percent, above net sales for the first nine months of fiscal 2006.  This improvement was due to increased distillery products sales.  Sales of ingredients in the first nine months of fiscal 2007 decreased compared to the same period the prior year.  The increase in distillery products sales resulted from higher unit sales and prices for both fuel grade and food grade alcohol combined with improved prices for distillers feed.  The decline in ingredients sales for the first nine months was due to reduced sales of specialty ingredients for both food and non-food applications, which more than offset a slight increase in sales of commodity ingredients.  Lower sales of specialty ingredients for food applications was mainly attributable to decreased unit sales of both specialty starches and proteins, which offset higher specialty starch and protein selling prices.  The increase in sales of commodity ingredients resulted from higher sales of commodity gluten, which offset reduced sales of commodity starch.   The rise in commodity gluten sales was due to improved prices, which offset lower unit sales.  Commodity starch prices also improved, but were offset by reduced unit sales compared to the first nine months of the prior fiscal year.

COST OF SALES

The cost of sales in the third quarter of fiscal 2007 rose by approximately $14.1 million, or nearly 20 percent, over cost of sales in the third quarter of fiscal 2006.  This increase was mainly due to higher grain costs and higher costs of supplies used in our manufacturing processes, partially offset by a decrease in energy costs related to lower natural gas prices.  Additionally, the increase was a function of higher maintenance and repairs related to planned plant outages associated with work on our distillery upgrades and higher depreciation expense resulting from a higher depreciable asset base due to certain assets being placed in service in the prior fiscal year.  The higher costs of manufacturing-related grain and supplies were primarily due to increased prices.  Wheat prices were approximately 20 percent higher than those experienced in the third quarter of fiscal 2006.  Wheat costs were not hedged in the third quarter of fiscal 2007.  The per-bushel cost of corn, adjusted for the impact of our hedging practices, averaged nearly 65 percent higher compared to a year ago.  For the third quarter of fiscal 2007, the cost of natural gas, adjusted for the impact of our hedging practices, decreased approximately 21 percent compared to the same period the prior year.

The cost of sales for the first nine months of fiscal 2007 increased by approximately $20.7 million, or 10 percent, compared to the first nine months of fiscal 2006 as a result of the same factors cited above in relation to the third quarter of fiscal 2007.   For the first nine months of fiscal 2007, the per-bushel cost of wheat, adjusted for the impact of our hedging practices, averaged nearly 26 percent higher compared to a year ago.  The per-bushel cost of corn, adjusted for the impact of our hedging practices, averaged nearly 30 percent higher compared to a year ago.  The cost of natural gas, adjusted for the impact of our hedging practices, decreased approximately 21 percent compared to the same period the prior year.

In connection with the purchase of raw materials, principally corn and wheat, for anticipated operating requirements, we enter into commodity contracts to hedge the risk of future grain price increases.  During the third quarter of fiscal 2007, we hedged approximately 24 percent of corn processed compared with approximately 42 percent of corn processed in the third quarter of fiscal 2006.   During the first nine months of fiscal 2007, we hedged approximately 36 percent of corn processed compared with approximately 40 percent of corn processed in the first nine months of fiscal 2006.  Raw material costs in the third quarter of fiscal 2007 included a net hedging gain of approximately $476,000 compared to a net hedging loss of $223,000 in the third quarter of fiscal 2006.

In the first nine months of fiscal 2007, raw material costs included a net hedging gain of approximately $500,000 compared to a net hedging loss of approximately $1.6 million in the first nine months of fiscal 2006.  During the first nine months of fiscal 2007, we experienced no losses on ethanol futures, compared to a loss of $24,000 on ethanol futures during the first nine months of the prior fiscal year.

18

These hedge transactions are highly effective.  Accordingly, nearly all related losses were entirely offset by reduced raw materials costs.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling, general and administrative expenses in the third quarter of fiscal 2007 decreased by approximately $40,000, or approximately 1 percent, compared to selling, general and administrative expenses in the third quarter of fiscal 2006 as increases in certain administrative costs were offset by lower salary and wage expenses.

Selling, general and administrative expenses in the first nine months of fiscal 2007 decreased by approximately $820,000 compared to the same period in fiscal 2006.  Increased costs related to the implementation of our Enterprise Resource Planning system and administrative activities were offset by reduced salary and management incentive costs.  Additionally, during the year-to-date period ended March 31, 2006, the Company accrued costs related to the unvested portion of its stock option incentive plan of approximately $272,000.  During the year-to-date period ended April 1, 2007, these costs were minimal as all outstanding stock options have vested

OTHER INCOME

Other income decreased approximately $168,000 and $91,000 in the quarter and year-to-date periods ended April 1, 2007, respectively, compared to the same periods of fiscal 2006.  These decreases were principally attributable to changes in interest capitalized as well as the effect of certain other non-recurring, non-operating revenue items.  It is our practice to credit other income for interest incurred that is capitalized.

INTEREST EXPENSE

Interest expense in the quarter and year-to-date period ended April 1, 2007 decreased compared to the same prior year periods.  The decrease in the year-to-date versus the comparable prior year period was primarily due to the impact of a make-whole premium paid in the first quarter of fiscal 2006 related to the refinancing of our notes with the Principal Mutual Life Insurance Company.  Additionally, we maintained lower balances on our outstanding debt during the quarter and year-to-date period ended April 1, 2007 than in the prior year periods.

TAXES AND INFLATION

For the quarter ended April 1, 2007, our income tax provision was $900,000 for an effective rate of 29.3 percent compared to a provision of $700,000 for the quarter ended March 31, 2006 for an effective rate of 26.1 percent.  For the year-to-date period ended April 1, 2007, our income tax provision was $9.3 million for an effective rate of 36.7 percent compared to a provision of $3.6 million for the year-to-date period ended March 31, 2006 for an effective rate of 35.3 percent.  The year-to-date changes were primarily the result of changes in permanent differences between income for financial reporting purposes and taxable income.

As of April 1, 2007, we had approximately $1.5 million in unused Kansas State Income Tax Credits (“tax credits”) related to capital investments we have made at our Atchison, Kansas facility.  These tax credits are available for use through June 30, 2015 and are contingent upon meeting certain criteria related to job training as well as wages paid relative to industry standards.  Additionally, application of these tax credits is contingent upon having sufficient taxable income in the state of Kansas.  It is our policy is to take

19

advantage of tax benefits whenever they are available.  We recognize these tax credits within our tax provision as these criteria are substantially satisfied.

NET INCOME

As the result of the foregoing factors, we experienced net income of $2,178,000 in the third quarter of fiscal 2007 compared to net income of $2,083,000 in the third quarter of fiscal 2006.  Our net income for the first nine months of fiscal 2007 was $15,989,000 compared to net income of $6,632,000 for the first nine months of fiscal 2006.

LIQUIDITY AND CAPITAL RESOURCES

The following table is presented as a measure of our liquidity and financial condition:  (Dollars in thousands)

	April 1,		June 30,
	2007		2006
Cash and cash equivalents	$	2,410	$	14,495
Working capital	49,940		44,469
Amounts available under lines of credit	18,000		20,000
Notes payable and long-term debt	13,394		16,151
Stockholders’ equity	146,672		134,912

CASH FLOW INFORMATION

Summary cash flow information follows for the year-to-date periods ended April 1, 2007 and March 31, 2006, respectively:  (Dollars in thousands)

	Year-to-Date Ended
	April 1,			March 31,
	2007			2006
Cash flows provided by (used for):
Operating activities	$	8,198		$	6,307
Investing activities	(16,691		)	(13,681		)
Financing activities	(3,592		)	576
Increase (decrease) in cash and cash equivalents	(12,085		)	(6,798		)
Cash and cash equivalents at beginning of year	14,495			10,384
Cash and cash equivalents at end of year	$	2,410		$	3,586

During the year-to-date period ended April 1, 2007, our consolidated cash decreased $12,085,000 compared to a decrease of $6,798,000 during the year-to-date period ended March 31, 2006.  The current year’s decrease was a result of increased investing cash outflows related to a higher level of capital expenditures and increased financing cash outflow primarily related to the purchase of treasury stock and a higher dividend payment.  These factors were partially offset by increased operating cash flow.  The

20

principal sources of cash are operating cash flow, proceeds from stock plans and the issuance of long-term debt.  Principal uses of cash are capital expenditures, payment of debt and the payment of dividends.

Operating Cash Flows.  Summary operating cash flow information for the year-to-date periods ended April 1, 2007 and March 31, 2006, respectively, is as follows:  (Dollars in thousands):

	Year-to-Date Ended
	April 1,			March 31,
	2007			2006
Net income	$	15,989		$	6,632
Depreciation	10,437			9,130
Gain on sale of assets	(3		)	(14		)
Deferred income taxes	706			(299		)
Changes in working capital items:
Segregated cash and investments	(1,663		)	—
Accounts receivable	(6,172		)	(3,927		)
Inventories	(6,001		)	(8,231		)
Accounts payable and accrued expenses	3,403			1,207
Deferred revenue	(1,146		)	(1,181		)
Income taxes payable	(5,934		)	3,808
Other	(1,418		)	(818		)
Net cash provided by operating activities	$	8,198		$	6,307

Cash flow from operations for the year-to-date period ended April 1, 2007 increased $1,891,000 to $8,198,000 from $6,307,000 for the year-to-date period ended March 31, 2006.  This improvement in operating cash flow was primarily attributable to the increase in net income of $9,357,000 as well as increases in deferred income taxes.  These factors, which served to increase operating cash flow, were partially offset by cash outflows for segregated cash and investments related to our hedge trading accounts as well as increases in accounts receivable and income taxes paid.  For the year to date period ended April 1, 2007, our inventory increased albeit at a lower amount than during the year to date period ended March 31, 2006.  This increase in inventory resulted primarily from higher prices for grain.  Additionally, operating cash flow was impacted by the timing of cash receipts and disbursements resulting in increases in accounts receivable, increases in accounts payable and accrued expenses as well as the pre-payment of certain expenses in the year-to-date period ended April 1, 2007.

Investing Cash Flows.  Net investing cash outflow was $16,691,000 for the year-to-date period ended April 1, 2007 compared to $13,681,000 for the year-to-date period ended March 31, 2006.  During the year-to-date period ended April 1, 2007, we made $16,778,000 in capital expenditures, including expenditures relating to distillery expansion at our Atchison plant, the acquisition of feed dryers at our Pekin plant, injection molding and packaging equipment at the Kansas City facility, equipment to improve the efficiency of our alcohol production facilities at Pekin as well as construction costs related to our new corporate headquarters and tech center in Atchison.  The effect of these capital expenditures was partially offset by the sale of certain equipment and vehicles of $87,000.

Financing Cash Flows.  Net Financing cash outflow for the year-to-date period ended April 1, 2007, was $3,592,000 compared to net cash inflow of $576,000 for the year-to-date period ended March 31, 2006.  During the year-to-date period ended April 1, 2007 we reduced long-term debt by $2,757,000.  Additionally, we purchased 80,500 shares of our common stock at an average price of $24.09 per share in connection with tax elections made by participants in our option and restricted stock plans and paid dividends of $3,343,000.  These cash outflows were partially offset by tax benefits of $2,446,000 related to  the

21

exercise of outstanding stock options and a draw of $2,000,000 under our line of credit for operating purposes.

For the year-to-date period ended March 31, 2006, we borrowed $7,000,000 from General Electric Capital Corporation (“GECC”) and used those proceeds to pay the unsecured notes payable to The Principal Mutual Life Insurance Company of $6,816,000.  We reduced long-term debt by $4,600,000.  Additionally, we had net drawings of $6,000,000 on our line of credit for operating purposes.  As a result, net cash inflows related to debt transactions in the year-to-date period ended March 31, 2006 were $1,584,000.

CONTRACTUAL OBLIGATIONS.

As of April 1, 2007, the amount of long-term debt was $13,394,000 compared to $16,151,000 at June 30, 2006.

Capital Expenditures.

In the year to date we have spent $16.8 million in capital expenditures and have commitments for an additional $12.6 million which we anticipate will be spent within the next 12 months.

We are currently exploring alternative sources of energy for our Pekin, Illinois plant in the form of a coal-fired steam generation facility.  In this regard we have applied for a license to operate a coal fired facility with the Illinois EPA.  However, we are in the preliminary stages of analysis and no decision has been made to proceed beyond the exploratory stage.

Our preliminary estimates suggest a project of this nature would cost approximately $60.0 million to install.  However, the actual cost to the company of engaging in such a project is not determinable at the moment.  We are exploring the types and availability of various financing alternatives that would require us to pay no more that a portion of the construction costs, and only expect to proceed on such a basis.  While there is no definitive time-frame for this project, if an operating license is granted and satisfactory financing arrangements are made, we estimate that it would take three to four years for the facility to be operational after we made a decision to proceed.

FINANCIAL COVENANTS

In connection with our loan and capital lease agreements, we are required to comply with certain covenants, a summary of which are as follows:

·We must maintain a current ratio (current assets to current liabilities) of 1.5 to 1.

·We must maintain minimum consolidated tangible net worth (stockholders’ equity less intangible assets) equal to the greater of (i) $86 million or (ii) the sum of $86 million plus 50 percent of consolidated net income since September 30, 2001.

·We must maintain a ratio of debt to tangible net worth of not more than 2.5 to 1.

·We may not permit consolidated funded debt (generally, asset acquisition related debt plus capitalized lease obligations) to exceed 60 percent of total capitalization.

·We must maintain at the end of each fiscal quarter a fixed charge ratio (generally, the ratio of (x) the sum of (a) net income [adjusted to exclude gains or losses from the sale or other disposition of capital assets and other matters] plus (b) provision for taxes plus (c) fixed charges, to (y) fixed charges) for the period of the four consecutive fiscal quarters ended as of the measurement date of 1.5 to 1.

LINES OF CREDIT

Our line of credit for $20.0 million, available for general corporate purposes, was amended on July 1, 2006 so that it now extends to July 1, 2007.  As of April 1, 2007, we had $2.0 million in outstanding borrowings under the line.

WORKING CAPITAL

Our working capital increased $5,471,000 from June 30, 2006 to April 1, 2007.  This increase was primarily the result of increased accounts receivable, inventories, prepaid expenses, deferred income tax assets and refundable income taxes as well as decreased accrued expenses, income taxes payable and deferred revenue. These factors, which led to an increase in working capital, were partially offset by reduced cash balances (including segregated cash held with our hedge trading broker), increased accounts payable and outstanding borrowings on our revolving credit facility.

22

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company produces its products from wheat, corn and milo and, as such, is sensitive to changes in commodity prices.  Grain futures and/or options are used as a hedge to protect against fluctuations in the market.  The information regarding inventories and futures contracts at June 30, 2006, as presented in the annual report, is not significantly different from April 1, 2007.

ITEM 4.CONTROLS AND PROCEDURES.

(a)Evaluation of disclosure controls and procedures.

Our Chief Executive Officer, President and Chief Financial Officer, after evaluating the design and effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) or 15d-15(e)) as of the end of the period covered by this report (the “Evaluation Date”), have concluded that as of the Evaluation Date, the Company’s disclosure controls and procedures were adequately designed and operating effectively to ensure that material information relating to the Company would be made known to them by others within the Company, particularly during the period in which this Form 10-Q Quarterly Report was being prepared.

(b).Changes in Internal Controls.

In our Report on Form 10-Q for the quarter ended December 31, 2006 , we disclosed that in the course of engaging the audit of employee benefit plans, management determined that certain employee benefit plans for the Atchison and Pekin plants that had previously been classified and reported as defined contribution plans did in fact contain aspects of defined benefit plans as well.  While the amounts involved were not material, we regarded this as a significant deficiency which we said we would address in future periods by establishing procedures to identify and evaluate existing contractual obligations (including but not limited to collective bargaining agreements) and the related impact of any changes in those contracts on financial reporting to allow management to evaluate the propriety of the accounting treatment for such plans. In our efforts to identify and evaluate existing contractual obligations and the related impact of any changes in those contracts on financial reporting, we have incorporated full executive management review of the periodic disclosures included in our quarterly reports.  These efforts include the addition of human resources and additional executive level management on our Disclosure Committee as well as full executive management review of quarterly SEC questionnaires generated by our external accounting firm, BKD LLP.   We believe that these efforts strengthen our disclosure control procedures as well as our internal controls as of the end of the third quarter, fiscal year 2007.

We also disclosed in our Form 10-Q report for December 31, 2006 that we had implemented certain changes to address material weaknesses identified in our Annual Report on Form 10-K for the fiscal year ended June 30, 2006.  One of the changes mentioned involved the implementation of  written procedures involving cycle counting and full physical inventories of maintenance materials at our Pekin, Illinois and Atchison, Kansas locations.  We continue to perform internal control testing of these control activities and therefore are unable to stated at this time that the related weakness noted in our Form 10-K has been addressed.

23

PART II – OTHER INFORMATION

ITEM 1.LEGAL PROCEEDINGS.

Reference is made to Item 3. Legal Proceedings in the Company’s Annual Report on Form 10-K for the year ended June 30, 2006 and to Part II, Item 1. Legal Proceedings in the Company’s Quarterly Reports on Form 10-Q for the quarters ended October 1, 2006 and December 31, 2006 for information regarding the following litigation matter to which the Company is a party:   MGP Ingredients, Inc. v. Mars, Incorporated et. al., Civil Action No 06-2318, U.S. District Court, District of Kansas.

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

The following table shows repurchase information regarding purchases by the Company of shares of its stock during the quarter ended April 1, 2007.

				Maximum
				Number (or
			Total Number	Approximate
			of shares (or	Dollar Value)
			Units)	of Shares (or
			Purchased as	Units (that
	Total	Average	Part of	May Yet Be
	Number	Price	Publicly	Purchased
	of Shares	Paid per	Announced	Under the
	(or Units)	Share	Plans or	Plans
Period	Purchased	(or Unit)	Programs	or Programs
January 1 – January 31, 2007	0	—	0
February 1 – February 28, 2007	0	—	0
March 1 – April 1, 2007	0	—	0	1,613,716	(a)

(a)On various dates, the Board of directors authorized the purchase of an aggregate of 6,000,000 shares of Common Stock of which 4,386,284 shares had been purchased as of April 1, 2007.  This program was first announced on June 5, 1997.  During the three months ended April 1, 2007, no shares were purchased under the program.  The program has no expiration date.

ITEM 6.	EXHIBITS
		3.1	Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 of the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.)
		3.2	Bylaws of the Company (Incorporated by reference to Exhibit 3(b) of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2006 (File Number 0-17196)
		*10.1	Employment Agreement with Dr. Sukh Bassi dated April 16, 2007.

24

*15.1	Letter from independent public accountants pursuant to paragraph (d) of Rule 10-01 of Regulation S-X (incorporated by reference to Independent Accountants’ Review Report at page 3 hereof)
*15.2	Letter from independent public accountants concerning the use of its Review Report in the Company’s Registration Statement Nos. 333-137593, 333-119860 and 333-51849
*31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Acts of 2002
*31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*31.3	Certification of President pursuant to Section 302 of the Sarbanes-Oxley Acts of 2002
*32.1	Certification of Chief Executive Officer furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
*32.2	Certification of Chief Financial Officer furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
*32.3	Certification of President pursuant to Section 302 of the Sarbanes-Oxley Acts of 2002

* Filed herewith

25

SIGNATURES

Pursuant to the requirements on the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	MGP INGREDIENTS, INC.
Date: May 10, 2007	By	/s/ Ladd M. Seaberg
		Ladd M. Seaberg, Chairman of the
		Board and Chief Executive Officer
Date: May 10, 2007	By	/s/ Brian T. Cahill
		Brian T. Cahill, Vice President
		and Chief Financial Officer

26

EX-10.1

Exhibit 10.1

EMPLOYMENT AGREEMENT

This Employment Agreement (“Agreement”) is made and entered into as of April 16, 2007, by and between MGP Ingredients, Inc., its subsidiaries and other affiliates (hereinafter referred to collectively as the “Company”), and Dr. Sukh Bassi (the “Employee”).

WHEREAS, the Company desires to employ the Employee in the capacity of Vice President Scientific Affairs, Chief Science Officer, and the Employee desires to be employed by the Company in such capacity and on the terms and conditions set forth in this Agreement;

NOW, THEREFORE, in consideration of the mutual covenants of the parties herein made, it is hereby agreed:

1.             Term of Agreement.  The term of this Agreement shall commence on the date hereof and end on June 30, 2010, unless sooner terminated as provided in Paragraph 9 of this Agreement; provided, however, that the Company may elect to renew this Agreement for an additional term of one (1) year at the end of the initial term by serving notice on Employee at least thirty (30) days prior to the expiration of the initial term, in accordance with the procedures set out in Paragraph 15 of this Agreement, that  the Company intends to extend the Agreement for such additional term of one year.   The Company shall not be required to show Cause for not extending the Agreement under the terms of this Paragraph, and in case of expiration of this Agreement after the initial term, the Company’s obligation to pay Base Salary and Bonus Compensation, if any,  or to provide Employee Benefits under this Agreement as defined in Paragraph 3 below, shall cease upon the expiration date of this Agreement.  The Employee’s rights to other compensation and benefits, if any, shall be determined under the Company’s benefit plans and policies applicable to Employee then in effect.

2.Employment and Duties.  The Company hereby agrees to employ the Employee, and the Employee hereby accepts employment, in the capacity above stated to perform such duties and responsibilities as are, from time to time, assigned to the Employee by the Company President, which may include, without limitation,  such duties and responsibilities as procuring, processing and administering grants, handling external and international science and government issues,  collaborating with industry and universities, representing the Company in its relationships with the IWGA, IFT, American Bakers Assn., American Society of Baking, and the Bio-Polymer Institute, representing the Company before the Kansas Bio Authority and USDA, serving as the Washington D.C. contact with the Kansas Congressional delegation and serving  as the Company contact for the National Assn. of Wheat Growers. Employee also shall attend internal Company meetings at the request of the Company President.  The Employee agrees to devote full business time and effort to the diligent and faithful performance of the Employee’s duties under the direction of the Company’s President.  Employee’s principal place of employment shall be moved to the Company’s new corporate office located in Atchison, Kansas.

3.Compensation and Benefits.

(a)Base Salary.  As compensation for the Employee’s services, the Employee shall be paid an annual base salary of Two Hundred Four Thousand Eight Hundred Dollars

1

($204,800) payable in regular payroll installments, less applicable withholdings (the “Base Salary”).  Employee’s base salary will be reviewed annually.

(b)Bonus Compensation.  The Employee shall, in addition to the Base Salary, be eligible to participate in a bonus program or plan structured on external science issues as from time to time may be adopted by the Company and in effect, if any.  The existence and terms of any such program or plan shall be determined solely at the discretion of the Company and participation is subject to the terms and conditions of any such program or plan.

(c)Employee Benefits.  The Employee shall be entitled to participate in the Company’s health, life, vacation, retirement and disability plans (“Employee Benefits”) in accordance with their respective terms.  Nothing herein shall be construed to limit the Company’s discretion to amend, terminate or otherwise modify any such Employee Benefits.

(d)Restricted Stock Grants.  The Employee will be entitled to receive outstanding restricted stock awards in accordance with their terms.

(e)Business Expenses.  The Company shall reimburse the Employee for entertainment and travel expenses related to the Company’s business in accordance with the policies of the Company applicable to the Employee on the date of this Agreement, subject to the right of the Company to modify its general policies relating to expense reimbursement for employees.

4.Confidential Information

(a)Definition

The term “Confidential Information” as used in this Agreement means (i) any and all information concerning the business and affairs of the Company or of  persons which whom the Company does business, such as customers, suppliers, licensors  and licensees (“Business Contacts”) which is not known by or generally available to the public in any form whatsoever that is disclosed in any manner by Company or a Business Contact to Employee or otherwise becomes known to Employee during or prior to the term of this Agreement, including without limitation information about products, product formulas and development, raw materials, packaging, manufacturing processes and methods, patents, patent applications, financial information, business plans and strategies, inventory techniques, pricing information, and customer and supplier lists and contact information, as well as reports, analyses, compilations, data, forecasts, studies and other materials which contain or otherwise reflect or are generated or derived from that information, and (ii) any and all information of  a Business Contact which is designated as confidential information pursuant to an agreement between the Business Contact and the Company.    Confidential Information also includes (a) any information of Company  in tangible or electronic form that is clearly and conspicuously marked, as practicable, as confidential, and (b) any orally disclosed information of Company that is designated confidential when disclosed, is reduced to writing within thirty days of disclosure, and is clearly and conspicuously marked as confidential.  In the latter case, the disclosure is Confidential Information until the thirty days have passed.

2

(b)Exceptions

Notwithstanding the foregoing, the Parties agree that the term “Confidential Information” will not include any information of the Company’s which is in the public domain prior to receipt by Employee or subsequent to the date of receipt without breach of this Agreement by Employee.

(c)Protection of Confidential Information

All Confidential Information previously supplied or known to Employee or which is supplied or becomes known to him pursuant to this Agreement will be maintained by him in confidence.  Employee will use a high degree of care and take all reasonable steps necessary to maintain the confidentiality of Confidential Information. Employee will not disclose Confidential Information to any third party unless either (i) he has been authorized to do so in writing by the President of the  Company or (ii) he is required to do so in the performance of his duties for the Company under this Agreement and (a) he has informed the third party that the Confidential Information to be disclosed is Confidential Information of the Company and (b) he has obtained from the third party a written confidentiality agreement either in a form then currently used by the Company or in a form approved for use in the particular instance by the President or counsel for the Company.   If Employee is required to disclose any of Company’s Confidential Information pursuant to a subpoena or similar judicial or governmental order, Employee will inform Company as soon as reasonably possible of the order and its requirements so that Company will have a reasonable opportunity to appear as necessary and contest the order.  Company is not obligated to supply any Confidential Information to Employee under this Agreement, makes no representation or warranty about the accuracy or completeness of any Confidential Information supplied to Employee under this Agreement, and has no obligation to update or correct inaccuracies which are or may become apparent in any Confidential Information.

(d)Ownership

Company is the sole owner of Confidential Information.  Upon request by Company, Employee agrees to return to Company, or to destroy and certify that he has destroyed, all Confidential Information provided by Company.  Unauthorized disclosure of Confidential Information by Employee could result in irreparable harm to Company, and entitle Company to seek injunctive and/or other appropriate relief.  Nothing in this Agreement will be deemed to grant to Employee a license directly or by implication, estoppel, or otherwise under any patent, patent application, trade secret or other intellectual property right, title or interest related to any Confidential Information disclosed pursuant to this Agreement.

5.Perfection of IP Rights

Company owns all right, title and interest in patents and patent applications based on inventions made in whole or in part at any time by Employee in the course of his employment by  Company, and it is anticipated that Employee may continue to make inventions for Company in his work for Company under this Agreement.  Employee will cooperate fully with Company and its patent counsel in preparing, filing and prosecuting Company patent applications based in

3

whole or in part on inventions made by Employee, the following being examples of that cooperation.  With respect to preparing patent applications, Employee will provide Company and counsel with all information in his possession, custody or control that relates to his invention, will work with counsel to draft sound patent applications, and will read successive drafts, paying particular attention to the final draft.  With respect to filing applications, Employee will sign a declaration of inventorship, an assignment to the Company of all right, title and interest in the application, and any other documents presented by counsel.  With respect to prosecution of the application, Employee will review and comment on Office Actions and related prior art, will sign further declarations of inventorship if necessary (for continuation-in-part applications, among others), and will participate in determinations relating to Patent Cooperation Treaty applications and the countries in which Company should go national.  To the extent that Company seeks to register or otherwise enhance protection of some non-patent aspect of its intellectual property that Employee helped create, Employee will participate fully in the processes required by law.  In that context, each registrable copyright will be considered a work made for hire (including software) and the  work and registration of the work will be owned by Company.

6.    Covenant Not to Compete.

During the Employee’s employment with the Company and for a period of two (2) years after the expiration or termination of this Agreement or of the Employee’s employment with the Company for any reason, the Employee agrees not to act as an owner, part owner, shareholder, joint venturer or operator, officer or director, employee, consultant or agent of any other person, firm, corporation, partnership, joint venture or other entity which is engaged in the development, manufacturer, and/or sale of any product that is substantially equivalent to any product made by the Company during the term of this Agreement. The foregoing provisions shall not prohibit the Employee from investing in any securities of any corporation whose securities are listed on a national securities exchange or traded in the over-the-counter market if the Employee shall own less than one percent (1%) of the outstanding voting stock of such corporation. The Employee agrees that a breach of the covenants contained herein and in paragraphs 4, 5, 7 and 8 will result in irreparable and continuing damage to the Company for which there will be no adequate remedy at law, and in the event of any breach of such agreement, the Company shall be entitled to injunctive and such other and further relief as may be proper, including damages, attorneys’ fees, and litigation costs.

7.Solicitation and Interference Prohibition.

During the Employee’s employment with the Company and for a period of two (2) years after the expiration or termination of this Agreement or of the Employee’s employment with the Company for any reason, the Employee shall not directly or indirectly, whether as an individual, or on behalf of any other person, firm, corporation, partnership, joint venture or entity whatsoever, solicit or endeavor to entice away from the Company any employee who is employed by the Company.  Additionally, during the Employee’s employment with the Company or for a period of two (2) years after the expiration or termination of this Agreement or of Employee’s employment with the Company for any reason, the Employee shall not, directly or indirectly through any other individual or entity, solicit the business of any customer of the Company, or solicit, entice, persuade or induce any individual or entity to terminate, reduce or refrain from forming, renewing or extending its relationship, whether actual or prospective, with

4

the Company. During Employee’s employment and for a period of two (2) years thereafter, Employee will not disrupt, damage, impair or interfere with the business of the Company or any of its affiliates or subsidiaries whether by way of interfering with or employing or seeking to employ its employees or by disrupting relationships with customers, agents, representatives or vendors or any others that have a business relationship with the Company.

8.Disparagement Prohibition.

The Employee acknowledges and agrees that as a result of his position with the Company, disparaging or critical statements made by the Employee may be uniquely detrimental to the Company’s interests and well-being.  Therefore, the Employee agrees to use his best efforts to assist the Company in promoting and preserving the good will and other business interests of the Company.  To this end, the Employee agrees to refrain at all times, both during the Employee’s employment and after the termination thereof for any reason, from making disparaging comments, or any public statements or remarks about the Company or its affiliates, subsidiaries, officers, employees or directors, unless previously approved by the Company’s Board of Directors.

9.Termination and Severance.

(a)Death or Disability.  In the event of the Employee’s death or if the Employee should become unable to perform the essential functions of the Employee’s position with  reasonable accommodation by the Company for a period of six (6) months (referred to as the “disability”), this Agreement, and the Company’s obligation to make further Base Salary or Bonus Compensation payments or provide Employee Benefits as defined in Paragraph 3 of this Agreement, shall terminate.  The Employee’s rights to other compensation and benefits, if any, shall be determined under the Company’s benefit plans and policies applicable to Employee then in effect.

(b)Termination for Cause by the Company.  By following the procedure set forth in Paragraph 9(e), the Company shall have the right to terminate this Agreement and the employment of the Employee for “Cause.”  For purposes of this Agreement, “Cause” is defined to mean, the Employee:

(i) engages in fraud, dishonesty, willful misconduct, willful mismanagement, or gross negligence;

(ii)is convicted of, or pleads nolo contendre to, a crime involving moral turpitude;

(iii)violates Paragraph 4 through 8; or

(iv)voluntarily terminates employment without Good Reason (as defined below).

If the employment of the Employee is terminated by the Company for Cause, this Agreement and the Company’s obligation to make further Base Salary and Bonus Compensation payments, if any, and to provide Employee Benefits as set forth in Paragraph 3 of this Agreement

5

shall thereupon immediately terminate.  The Employee’s rights to other compensation and benefits, if any, shall be determined under the Company’s benefit plans and policies applicable to the Employee then in effect.

(c)Termination for Good Reason by the Employee.  By following the procedure set forth in Paragraph 9(e), the Employee shall have the right to terminate this Agreement and the Employee’s employment with the Company for “Good Reason” in the following circumstances:

(i)Change of Location. The Company shall require Employee to permanently (for more than three continuous months during any 12 month period) relocate from the Atchison/Kansas City, Kansas vicinity; or

(ii)Reduction of Total Compensation Opportunity.  The Company  reduces the Employee’s Base Salary below the amount specified in Paragraph 3(a).

Any notification of the Employee’s intent to terminate the Agreement for Good Reason under this Paragraph must be given, pursuant to Paragraph 9(e), no later than thirty (30) days after the Employee learns, or reasonably should become aware, of the occurrence of the event giving rise to the right to terminate for Good Reason.

If the employment of the Employee is terminated by the Employee for Good Reason (as defined above), the Company’s obligation to make further Bonus Compensation payments, if any, or to provide Employee Benefits under this Agreement shall cease on the effective date of such termination, but the Employee will be entitled to receive Base Salary to the end of the term of the Agreement then in effect.  The payment shall be paid in accordance with the Company’s customary payroll policies until the end of the term, unless otherwise agreed to by the Employee and the Company at the time of termination, or unless prohibited under law, rule or regulation.    The Employee’s rights to other compensation and benefits, if any, shall be determined under the Company’s benefit plans and policies applicable to the Employee then in effect.

(d)Termination by Company Without Cause or by Employee Without Good Reason.  The Company may terminate this Agreement and the Employee’s employment without Cause at any time, and in such event the Company’s obligation to make further Bonus Compensation payments, if any, and to provide Employee Benefits under this Agreement shall cease on the effective date of such termination, but the Employee shall be entitled to Base Salary to the end of the term of the Agreement then in effect.  The payment of Base Salary shall be made  in accordance with the Company’s customary payroll policies unless otherwise agreed by the Employee and the Company at the time of termination, or unless prohibited under law, rule or regulation. The Employee’s rights to other compensation and benefits, if any, shall be determined under the Company’s benefit plans and policies applicable to the Employee then in effect.

The Employee may voluntarily terminate this Agreement and the Employee’s employment without Good Reason at any time, but in such event the Employee shall not be entitled to any further Base Salary or Bonus Compensation, if any, or to further Employee

6

Benefits under this Agreement.  The Employee’s rights to other compensation and benefits, if any, shall be determined under the Company’s benefit plans and policies applicable to the Employee then in effect.

(e)Notice of Termination.  The party proposing to terminate this Agreement and the employment of the Employee for Cause or Good Reason, as the case may be, under Paragraph 9(b) or 9(c) above shall give written notice to the other, specifying the reason therefore with particularity.  The effective date of termination shall be the date on which notification of termination shall be mailed in accordance with Paragraph 15 of this Agreement, unless a different termination date shall be designated by the party giving notice or agreed upon by the Employee and the Company.

(f)Expiration of Term of Agreement.  At the expiration of the term of this Agreement as defined in Paragraph 1 above, if the Agreement has not been previously terminated under Paragraph 9 of this Agreement, all duties and obligations of the parties under this Agreement, except those set out in Paragraphs 4 through 8, shall cease.

(g)Survival of Certain Provisions.  Notwithstanding the expiration or termination of this Agreement, and the Employee’s employment with the Company for any reason under this Agreement, the provisions of Paragraphs 4 through 8 survive any such termination and shall be binding upon the Employee and the Company in accordance with the provisions of  such Sections.

10.Litigation Assistance.  Employee will cooperate and assist the Company in the investigation, prosecution and resolution of any pending or threatened legal action, arbitration or administrative proceeding or investigation involving any matter that arose before or during Employee’s employment by the Company, including, without limitation, preparation activities, testifying as a witness and providing relevant information to the Company.  Employee further agrees he will not take any actions which would cause him to be subpoenaed in any investigation, prosecution, or resolution of any pending or threatened legal action, arbitration, or administrative or judicial proceeding and will not testify in any such proceedings absent a valid subpoena or at the Company’s request.

11.Arbitration.  Except as otherwise provided in this Paragraph, the parties hereby agree that any dispute arising under this Agreement or any claim for breach or violation of any provision of this Agreement shall be submitted to arbitration, pursuant to the National Rules for the Resolution of Employment Disputes of the American Arbitration Association (“AAA”), to a single arbitrator selected by mutual agreement of the parties or, if the parties do not mutually agree on the arbitrator, in accordance with the rules of the AAA.  The award determination of the arbitrator shall be final and binding upon the parties.  Either party shall have the right to bring an action in any court of competent jurisdiction to enforce this Paragraph and to enforce any arbitrator’s award rendered pursuant to this Paragraph.  The venue for all proceedings in arbitration under this provision, and for any judicial proceedings related to the arbitration, shall be in Kansas City, Missouri.  Nothing in this Paragraph, however, shall prevent the Company from seeking injunctive relief to preserve its rights under Paragraphs 4 through 8 of this Agreement.

7

12.Severability.  If any one or more of the provisions of this Agreement shall be held invalid or unenforceable, the remaining provisions shall remain valid and enforceable to the maximum extent permitted by law.

13.Entire Agreement.  This Agreement contains a statement of all agreements and understandings between the Employee and the Company on the subject matters covered by the Agreement, and it replaces and supersedes all prior contracts and agreements between the Employee and the Company concerning such matters.  No additions or modifications to this Agreement will be effective unless made in writing and signed by the Employee and the Company.

14.Binding Effect.  This Agreement shall be binding upon and inure to the benefit of the personal representatives, heirs and assigns of the Employee and to any successors in interest and assigns of the Company.

15.           Notices.  All notices required or permitted to be given hereunder shall be sent registered or certified mail, addressed to the respective parties at their addresses set forth below:

To the Employee:Sukh Bassi

1502 Hillcrest Court

Atchison, Kansas  66002

To the Company:MGP Ingredients, Inc.

100 Commercial Street

P.O. Box 130

Atchison, Kansas 66002-0130

or such other address as a party hereto may notify the other in writing.

16.Applicable Law.  This Agreement, or any portion thereof, shall be interpreted in accordance with the laws of the State of Kansas.

17.Assignment.  The rights and obligations of the Company under this Agreement shall inure to the benefit of and shall be binding upon the successors and assigns of the Company.  Employee may not assign any of his rights or delegate any of his duties or obligations under this Agreement without the Company’s express written consent.

18.Non-Waiver Provision.  The failure of either party of this Agreement to insist upon strict adherence to any term of this Agreement, or to object to any failure to comply with any provision of this Agreement, shall not (a) constitute or operate as a waiver of that term or provision, (b) estop that party from enforcing that term or provision, or (c) preclude that party from enforcing that term or provision or any other term or provision.  The receipt of a party to this Agreement of any benefit from this Agreement shall not effect a waiver or estoppel of the right of that party to enforce any provision of this Agreement.

ALL SIGNATORIES ACKNOWLEDGE THEY HAVE CAREFULLY READ THIS AGREEMENT, WERE PROVIDED AN OPPORTUNITY TO EXAMINE THE

8

ARBITRATION RULES AND CONSULT WITH COUNSEL BEFORE SIGNING, AND UNDERSTAND THAT BY SIGNING THIS AGREEMENT, BOTH PARTIES WAIVE RIGHTS TO TRIAL BY COURT OR JURY, EXCEPT AS EXPRESSLY PROVIDED HEREIN.

IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the day and year first written above.

EMPLOYEE	MGP INGREDIENTS, INC.
/s/ Sukh Bassi	By:	/s/ David E. Rindom
	Name: David E. Rindom
	Title:		Vice President - Human Resources

9

EX-15.2

Exhibit 15.2

Accountants’ Acknowledgement

We acknowledge the incorporation by reference in the Registration Statements on Form S-8 (Registration Nos. 333-137593, 333-119860 and 333-51849) of MGP Ingredients, Inc. (Company) of our report dated May 9, 2007, included with the Quarterly Report on Form 10-Q for the quarter ended April 1, 2007.  Pursuant to Rule 436(c) under the Securities Act of 1933, this report should not be considered part of the Registration Statement prepared or certified by us within the meaning of Sections 7 and 11 of the Act.

	/s/ BKD, LLP
Kansas City, Missouri
May 9, 2007

Twelve Wyandotte Plaza       120 West 12th Street, Suite 1200       Kansas City, MO  64105-1936       816 221-6300       Fax 816-221-6380

Beyond Your Numbers

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Laidacker M. Seaberg, certify that:

1.I have reviewed this quarterly report on Form 10-Q of MGP Ingredients, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal conrtrol over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonable likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2007
	/s/ Laidacker M. Seaberg
	Laidacker M. Seaberg
	Chairman of the Board and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Brian T. Cahill, certify that:

1.I have reviewed this quarterly report on Form 10-Q of MGP Ingredients, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal conrtrol over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonable likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2007
	/s/ Brian T. Cahill
	Brian T. Cahill
	Vice President and Treasurer and Principal Financial and Accounting Officer

EX-31.3

Exhibit 31.3

CERTIFICATION

I, Timothy W. Newkirk, certify that:

1.I have reviewed this quarterly report on Form 10-Q of MGP Ingredients, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal conrtrol over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonable likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2007
	/s/ Timothy W. Newkirk
	Timothy W. Newkirk
	President

EX-32.1

Exhibit 32.1

CERTIFICATION

OF

PERIODIC REPORT

I, Laidacker M. Seaberg, Chairman of the Board and Chief Executive Officer of MGP Ingredients, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1) the Quarterly Report on Form 10-Q of the Company for the quarter ended April 1, 2007 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 10, 2007
	/s/ Laidacker M. Seaberg
	Laidacker M. Seaberg
	Chairman of the Board and Chief Executive Officer

[A signed original of this written statement required by Section 906 has been provided to MGP Ingredients, Inc. and will be retained by MGP Ingredients, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.]

EX-32.2

Exhibit 32.2

CERTIFICATION

OF

PERIODIC REPORT

I, Brian T. Cahill, Vice President and Chief Financial Officer of MGP Ingredients, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1) the  Quarterly Report on Form 10-Q of the Company for the quarter ended April 1, 2007 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 10, 2007
	/s/ Brian T. Cahill
	Brian T. Cahill
	Vice President and Chief Financial Officer

[A signed original of this written statement required by Section 906 has been provided to MGP Ingredients, Inc. and will be retained by MGP Ingredients, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.]

EX-32.3

Exhibit 32.3

CERTIFICATION

OF

PERIODIC REPORT

I, Timothy W. Newkirk, President of MGP Ingredients, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1) the Quarterly Report on Form 10-Q of the Company for the quarter ended April 1, 2007 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 10, 2007
	/s/ Timothy W. Newkirk
	Timothy W. Newkirk
	President

[A signed original of this written statement required by Section 906 has been provided to MGP Ingredients, Inc. and will be retained by MGP Ingredients, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.]